Consun Pharmaceutical Group Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG2524A1031
HKD
19.36
1.27 (7.02%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

High Management Efficiency with a high ROE of 21.94%

 
2

Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 42.92

 
3

Poor long term growth as Operating profit has grown by an annual rate 20.17% of over the last 5 years

 
4

Positive results in Dec 24

5

With ROE of 23.09%, it has a Fair valuation with a 2.65 Price to Book Value

6

Consistent Returns over the last 3 years

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

HKD 13,262 Million ()

stock-summary
P/E

12.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.87

stock-summary
Return on Equity

23.09%

stock-summary
Price to Book

2.78

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
28.89%
0%
28.89%
6 Months
45.35%
0%
45.35%
1 Year
135.24%
0%
135.24%
2 Years
268.06%
0%
268.06%
3 Years
330.22%
0%
330.22%
4 Years
374.51%
0%
374.51%
5 Years
481.38%
0%
481.38%

Consun Pharmaceutical Group Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
15.43%
EBIT Growth (5y)
20.17%
EBIT to Interest (avg)
42.92
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.88
Sales to Capital Employed (avg)
0.66
Tax Ratio
10.07%
Dividend Payout Ratio
49.91%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
121.96%
ROE (avg)
21.94%

Valuation key factors

Factor
Value
P/E Ratio
12
Industry P/E
Price to Book Value
2.65
EV to EBIT
7.41
EV to EBITDA
7.03
EV to Capital Employed
13.91
EV to Sales
2.41
PEG Ratio
0.69
Dividend Yield
NA
ROCE (Latest)
187.86%
ROE (Latest)
23.09%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Bullish
Bullish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Consun Pharmaceutical Group Ltd."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is 5.20% vs 10.41% in Dec 2022",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is 9.31% vs 12.37% in Dec 2022",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,862.10",
          "val2": "2,720.70",
          "chgp": "5.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "932.70",
          "val2": "903.30",
          "chgp": "3.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "23.50",
          "val2": "12.70",
          "chgp": "85.04%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "869.10",
          "val2": "795.10",
          "chgp": "9.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "295.90%",
          "val2": "299.60%",
          "chgp": "-0.37%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'23stock-summary

Dec'23
Dec'22
Change(%)
Net Sales
2,862.10
2,720.70
5.20%
Operating Profit (PBDIT) excl Other Income
932.70
903.30
3.25%
Interest
23.50
12.70
85.04%
Exceptional Items
0.00
0.00
Consolidate Net Profit
869.10
795.10
9.31%
Operating Profit Margin (Excl OI)
295.90%
299.60%
-0.37%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2023 is 5.20% vs 10.41% in Dec 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2023 is 9.31% vs 12.37% in Dec 2022

stock-summaryCompany CV
About Consun Pharmaceutical Group Ltd. stock-summary
stock-summary
Consun Pharmaceutical Group Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available